Company profile: WellGen
1.1 - Company Overview
Company description
- Provider of plant-based wellness products discovered and developed using nutrigenomics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to WellGen
Verge Genomics
HQ: United States
Website
- Description: Provider of an AI-powered, all-in-human drug discovery platform (CONVERGE®) integrating proprietary human genomics and computational tools to predict new drugs; developer of VRG50635, a PIKfyve inhibitor for ALS; and collaborator with industry and academic partners, including Alexion/AstraZeneca Rare Disease, Eli Lilly, and SITraN, to co-develop clinical-stage and novel therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verge Genomics company profile →
Chroma Medicine
HQ: United States
Website
- Description: Provider of genetic medicines built on an epigenetic editing platform that uses programmable editors to silence, activate, or regulate multiple genes by controlling chromatin conformation; single-dose genomic medicines for precise, predictable, durable treatment; multiplex epigenetic editing to enhance allogeneic CAR T cells; and a PCSK9-targeted editor to lower cholesterol and LDL-C.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chroma Medicine company profile →
Helix
HQ: United States
Website
- Description: Provider of population genomics solutions to advance research and integrate genomic data into clinical care, offering Exome+® sequencing; an integrated platform to collect, sequence, interpret, store, and share genetic information with a DNA product marketplace; Helix Insights; population genomics programs; diagnostic testing for hereditary cancer, cardiovascular disorders, pharmacogenomics, and proactive screening; and large-scale research programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Helix company profile →
CosmosID
HQ: United States
Website
- Description: Provider of metagenomics and bioinformatics services for rapid identification of microorganisms in various samples, offering strain-level analysis via proprietary pipeline and database to detect bacteria, viruses, fungi, and more. Provides sequencing services (amplicon, shallow/deep shotgun, bacterial isolate) and CosmosID-HUB Microbiome, an online platform with pipelines for amplicon and shotgun data, plus targeted tests and whole genome analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CosmosID company profile →
GenturaDx
HQ: United States
Website
- Description: Provider of molecular diagnostic solutions focused on making multiplexed molecular testing affordable and practical for any laboratory to perform. Offers the IDbox system and single-use cassette designed to circumvent barriers of cost, automation and performance, facilitating in-house lab testing for actionable results.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenturaDx company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for WellGen
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to WellGen
2.2 - Growth funds investing in similar companies to WellGen
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for WellGen
4.2 - Public trading comparable groups for WellGen
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →